ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies Ltd.verified

IPA

Price:

$1.62

Market Cap:

$79.44M

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, V...[Read more]

Industry

Biotechnology

IPO Date

2002-01-07

Stock Exchange

NASDAQ

Ticker

IPA

The PE Ratio as of March 2026 (TTM) for ImmunoPrecise Antibodies Ltd. (IPA) is -2.45

According to ImmunoPrecise Antibodies Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -2.45. This represents a change of -50.09% compared to the average of -4.92 of the last 4 quarters.

ImmunoPrecise Antibodies Ltd. (IPA) Historical PE Ratio (quarterly & annually)

How has IPA PE Ratio performed in the past?

The mean historical PE Ratio of ImmunoPrecise Antibodies Ltd. over the last ten years is -38.84. The current -2.45 PE Ratio has changed 531.96% with respect to the historical average. Over the past ten years (40 quarters), IPA's PE Ratio was at its highest in in the December 2015 quarter at -0.19. The PE Ratio was at its lowest in in the October 2020 quarter at -87.29.

Quarterly (TTM)
Annual

Average

-38.84

Median

-7.33

Minimum

-318.57

Maximum

-0.67

ImmunoPrecise Antibodies Ltd. (IPA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ImmunoPrecise Antibodies Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 611.10%

Maximum Annual PE Ratio = -0.67

Minimum Annual Increase = -98.71%

Minimum Annual PE Ratio = -318.57

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.67-60.65%
2024-1.71-46.34%
2023-3.19-61.29%
2022-8.24-69.38%
2021-26.90163.72%
2020-10.2058.96%
2019-6.42-23.76%
2018-8.42105.52%
2017-4.09-98.71%
2016-318.57611.10%

ImmunoPrecise Antibodies Ltd. (IPA) Average PE Ratio

How has IPA PE Ratio performed in the past?

The current PE Ratio of ImmunoPrecise Antibodies Ltd. (IPA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.86

5-year avg

-8.14

10-year avg

-38.84

ImmunoPrecise Antibodies Ltd. (IPA) PE Ratio vs. Peers

How is IPA’s PE Ratio compared to its peers?

ImmunoPrecise Antibodies Ltd.’s PE Ratio is less than IGM Biosciences, Inc. (-1.46), greater than Jade Biosciences, Inc. (-7.73), less than Quince Therapeutics, Inc. (-0.10), greater than Landos Biopharma, Inc. (-6.56), less than Surface Oncology, Inc. (-0.91), less than Heat Biologics, Inc. (-0.00), less than Berkeley Lights, Inc. (-0.84), less than Reneo Pharmaceuticals, Inc. (0), less than Achilles Therapeutics plc (-0.85), less than Miromatrix Medical Inc. (-2.34),

Build a custom stock screener for ImmunoPrecise Antibodies Ltd. (IPA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmunoPrecise Antibodies Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmunoPrecise Antibodies Ltd. (IPA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmunoPrecise Antibodies Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is ImmunoPrecise Antibodies Ltd.'s PE Ratio?

How is the PE Ratio calculated for ImmunoPrecise Antibodies Ltd. (IPA)?

What is the highest PE Ratio for ImmunoPrecise Antibodies Ltd. (IPA)?

What is the 3-year average PE Ratio for ImmunoPrecise Antibodies Ltd. (IPA)?

What is the 5-year average PE Ratio for ImmunoPrecise Antibodies Ltd. (IPA)?

How does the current PE Ratio for ImmunoPrecise Antibodies Ltd. (IPA) compare to its historical average?